2025年3月18日周二，Alector Inc. (NASDAQ: ALEC) 参加了虚拟CNS论坛，展示了其神经退行性疾病治疗项目的战略概况。公司展示了其强大的研发管线，包括前景看好的三期临床试验，同时也讨论了部分研究未能达到主要终点的挑战。

Directly inherited dementia is rare, but in around three in every 10 people with FTD a strong family history of the condition is known. In these cases the cause is likely to be genetic. This is known ...

DelveInsight's "EMPAVELI Market Size, Forecast, and Market Insight Report" highlights the details around EMPAVELI, a complement inhibitor indicated to treat adult patients with PNH. The report ...